Palmitoylethanolamide, GPR55 agonist; endogenous cannabinoid (TBI1297)
$108.00 – $432.00
GPR55 agonist; endogenous cannabinoid
SKU | Stock | SIZE (mg) | Price | Quantity | ||
---|---|---|---|---|---|---|
TBI1297-20MG | Yes | 20 MG | $108.00 | |||
TBI1297-100MG | Yes | 100 MG | $432.00 |
- Description
- Terms
- Additional information
- Documents
- Reviews (0)
Description
Product Details
Formal Name: N-(2-hydroxyethyl)palmitamide
Alternate Names: PEA
Molecular Formula: C18H37NO2
Formula Weight: 299.50
CAS Number: 544-31-0
Purity: >98%
Formulation: powder
Solubility: Soluble in DMSO (up to 25 mg/ml) or in Ethanol (up to 25 mg/ml).
Storage: -20°C
Stability: ≥ 2 years.
Applications
GPR55 agonist; endogenous cannabinoid
Functions
Endogenous cannabinoid. Weak ligand for CB1 (Ki=23.8 µM) and CB2 (Ki=13.9 µM) receptor. Selective agonist at GPR55. Inhibits expression of fatty acid amide hydrolase (FAAH). Displays immunosuppressant and anti-inflammatory activity and reduces granuloma-induced hyperalgesia.
Application Procedures
First dissolved in DMSO (up to 25 mg/ml) or in Ethanol (up to 25 mg/ml), then diluted to aqueous buffer. Solutions in water may be stored at -20°C for up to 3 months.
Additional information
SIZE (mg) | 20 MG, 100 MG |
---|
Be the first to review “Palmitoylethanolamide, GPR55 agonist; endogenous cannabinoid (TBI1297)”
You must be logged in to post a review.
Reviews
There are no reviews yet.